Picture of Biosyent logo

RX Biosyent Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Momentum

Relative Strength (%)
1m-2.98%
3m-13.23%
6m-7.82%
1yr-10.19%
Volume Change (%)
10d/3m-60.89%
Price vs... (%)
52w High-28.3%
50d MA-2.81%
200d MA-11.7%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)13.76
PEG Ratio (f)0.83
EPS Growth (f)19.8%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value2.69
Price to Tang. Book2.77
Price to Free Cashflow19.28
Price to Sales3.2
EV to EBITDA7.48

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital23.06%
Return on Equity19.38%
Operating Margin28.74%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueCA$m20.7621.5321.4222.3328.6227.429.89.81%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+21.09+10.05-9.12-19.44+68.37-11.89+23.26n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Biosyent EPS forecast chart

Profile Summary

BioSyent Inc. is a Canada-based pharmaceutical company. The Company is focused on in-licensing or acquiring pharmaceutical and other healthcare products. It owns a legacy business that manufactures and markets Protect-It, a bio-friendly non-toxic product used in agriculture, which is operated by its subsidiary Hedley Technologies Ltd. It is a non-chemical, food-safe grain insecticide, which is used as a preventative treatment against insect infestations in stored grains and is marketed in Canada and the United States. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Powder 15, Proktis-M, RepaGyn, and cTIBELLA. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell is designed for ease of use and with patient comfort and safety in mind. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.

Directors

Last Annual
December 31st, 2021
Last Interim
September 30th, 2022
Incorporated
May 19th, 1999
Public Since
May 22nd, 1981
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
ca flag iconTSX Venture Exchange
Shares in Issue
12,370,161

RX Share Price Performance

Upcoming Events for RX

Q4 2022 Biosyent Inc Earnings Release

Biosyent Inc Annual Shareholders Meeting

Q1 2023 Biosyent Inc Earnings Release

Similar to RX

Picture of Acasti Pharma logo

Acasti Pharma

ca flag iconTSX Venture Exchange

Picture of Aequus Pharmaceuticals logo

Aequus Pharmaceuticals

ca flag iconTSX Venture Exchange

Picture of Avricore Health logo

Avricore Health

ca flag iconTSX Venture Exchange

Picture of Cannara Biotech logo

Cannara Biotech

ca flag iconTSX Venture Exchange

Picture of Decibel Cannabis logo

Decibel Cannabis

ca flag iconTSX Venture Exchange

FAQ

Or unlock with your email

Or unlock with your email